Sign in

CIK 0001438533 · Large accelerated filer

Travere Therapeutics, Inc.

Sign in to watch
Ticker
TVTX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
operating
EIN
262383102
Phone
888-969-7879
Business address
3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
Former names
Retrophin, Inc., Desert Gateway, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$80,128,453
in 11 filings, $80.1M under 10b5-1 plans

Net −$80,128,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
  2. Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
  3. ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
  4. Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
  5. Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-01-31 Dube Eric M Chief Executive Officer Grant or award +15,000 160,079
2021-01-31 Clague Laura Chief Financial Officer Grant or award +5,000 39,473
2021-01-21 Dube Eric M Chief Executive Officer Grant or award · Employee stock option (right to buy) +212,660 212,660
2021-01-21 ROTE WILLIAM E. Senior Vice President, R&D Grant or award +15,000 39,582
2021-01-21 ROTE WILLIAM E. Senior Vice President, R&D Grant or award · Employee stock option (right to buy) +57,500 57,500
2021-01-21 Rosenberg Noah L. Chief Medical Officer Grant or award +15,000 42,720
2021-01-21 Rosenberg Noah L. Chief Medical Officer Grant or award · Employee stock option (right to buy) +57,500 57,500
2021-01-21 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award +15,000 39,055
2021-01-21 REED ELIZABETH E SVP, GC & Corporate Secretary Grant or award · Employee stock option (right to buy) +57,500 57,500
2021-01-21 Heerma Peter Chief Commercial Officer Grant or award +15,000 58,220
2021-01-21 Heerma Peter Chief Commercial Officer Grant or award · Employee stock option (right to buy) +57,500 57,500
2021-01-21 Clague Laura Chief Financial Officer Grant or award +15,000 34,473
2021-01-21 Clague Laura Chief Financial Officer Grant or award · Employee stock option (right to buy) +57,500 57,500
2021-01-21 Dube Eric M Chief Executive Officer Grant or award +57,260 145,079
2021-01-21 Dube Eric M Chief Executive Officer Grant or award · Employee stock option (right to buy) +212,600 212,600
2021-01-06 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −688 $27.01 $19K 24,055
2021-01-06 Dube Eric M Chief Executive Officer Sale −3,438 $27.01 $93K 87,819
2021-01-05 REED ELIZABETH E SVP, GC & Corporate Secretary Sale −688 $26.65 $18K 24,743
2021-01-05 Dube Eric M Chief Executive Officer Sale −3,438 $26.65 $92K 91,257
2020-12-15 ASELAGE STEVE Director Sale −5,549 $26.02 $144K 196,667

Page 39 of 51 · 1,020 trades